# Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

> **NCT04632121** · — · UNKNOWN · sponsor: **Ahmed Abdel Nasser Abdel Rady** · enrollment: 300 (estimated)

## Conditions studied

- Nicorandil

## Interventions

- **DRUG:** Nicorandil 20 MG

## Key facts

- **NCT ID:** NCT04632121
- **Lead sponsor:** Ahmed Abdel Nasser Abdel Rady
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-12-29
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04632121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04632121, "Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04632121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*